J.A. Hartley

502 total citations
22 papers, 424 citations indexed

About

J.A. Hartley is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, J.A. Hartley has authored 22 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 5 papers in Organic Chemistry and 4 papers in Oncology. Recurrent topics in J.A. Hartley's work include DNA and Nucleic Acid Chemistry (8 papers), Cancer therapeutics and mechanisms (7 papers) and Synthesis and Biological Evaluation (4 papers). J.A. Hartley is often cited by papers focused on DNA and Nucleic Acid Chemistry (8 papers), Cancer therapeutics and mechanisms (7 papers) and Synthesis and Biological Evaluation (4 papers). J.A. Hartley collaborates with scholars based in United Kingdom, United States and Italy. J.A. Hartley's co-authors include Robert L. Souhami, Neil W. Gibson, Mark Berardini, John Butler, John P. Bingham, Stephen Forrow, Simon McAdam, Stuart H. Yuspa, Moses Lee and Keith Grimaldi and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and Biochemistry.

In The Last Decade

J.A. Hartley

22 papers receiving 414 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.A. Hartley United Kingdom 12 311 155 76 68 45 22 424
C. Caroline O’Hare United Kingdom 14 377 1.2× 185 1.2× 54 0.7× 101 1.5× 45 1.0× 24 525
James D. Liddil United States 12 253 0.8× 97 0.6× 54 0.7× 86 1.3× 46 1.0× 19 427
C. Yu United States 6 484 1.6× 153 1.0× 130 1.7× 148 2.2× 54 1.2× 7 654
Mark D. Prairie United States 9 358 1.2× 162 1.0× 70 0.9× 71 1.0× 44 1.0× 21 438
Judith Markovits France 15 642 2.1× 198 1.3× 139 1.8× 171 2.5× 28 0.6× 24 764
Kazuhiro Fukasawa Japan 11 345 1.1× 183 1.2× 63 0.8× 203 3.0× 23 0.5× 19 538
Gregory A. Rener United States 11 285 0.9× 336 2.2× 28 0.4× 93 1.4× 41 0.9× 20 596
A. S. Prakasha Gowda United States 12 251 0.8× 154 1.0× 24 0.3× 46 0.7× 45 1.0× 23 408
Rita Fiaschi Italy 17 189 0.6× 358 2.3× 49 0.6× 105 1.5× 35 0.8× 36 601
Eduardo J. Salustiano Brazil 10 180 0.6× 90 0.6× 115 1.5× 67 1.0× 64 1.4× 18 362

Countries citing papers authored by J.A. Hartley

Since Specialization
Citations

This map shows the geographic impact of J.A. Hartley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.A. Hartley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.A. Hartley more than expected).

Fields of papers citing papers by J.A. Hartley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.A. Hartley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.A. Hartley. The network helps show where J.A. Hartley may publish in the future.

Co-authorship network of co-authors of J.A. Hartley

This figure shows the co-authorship network connecting the top 25 collaborators of J.A. Hartley. A scholar is included among the top collaborators of J.A. Hartley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.A. Hartley. J.A. Hartley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wells, Geoffrey, Terence C. Jenkins, Tom Ellis, et al.. (2010). 526 A potent PBD-heterocyclic polyamide conjugate targeting an ICB2 transcription factor binding site. European Journal of Cancer Supplements. 8(7). 168–168. 1 indexed citations
2.
Sarker, Debashis, David A. Anderson, Victoria J. Spanswick, et al.. (2008). Preliminary results of a Cancer Research UK phase I trial combining the dinitrobenzamide prodrug CB1954 (tretazicar) and the NQO2 substrate EP-0152R (caricotamide) intravenously (IV) every 3 weeks. Journal of Clinical Oncology. 26(15_suppl). 2505–2505. 2 indexed citations
3.
4.
Mould, Tim, et al.. (2004). 263 Enhanced Repair of DNA Interstrand Crosslinking in Ovarian Cancer Cells From Patients Following Treatment With Platinumbased Chemotherapy. International Journal of Gynecological Cancer. 14. 75–75. 2 indexed citations
5.
O’Hare, C. Caroline, J.A. Hartley, Siobhán McClean, et al.. (1998). Synthesis of new bifunctional compounds which selectively alkylate guanines in DNA.. PubMed. 13(7). 749–68. 3 indexed citations
6.
7.
8.
Grimaldi, Keith, Simon McAdam, Robert L. Souhami, & J.A. Hartley. (1994). DNA damage by anti-cancer agents resolved at the nucleotide level of a single copy gene: evidence for a novel binding site for cisplatin in cells. Nucleic Acids Research. 22(12). 2311–2317. 37 indexed citations
9.
Lee, Moses, et al.. (1994). GC Sequence Specific Recognition by an N-Formamido, C-Terminus-Modified and Imidazole-Containing Analog of Netropsin. Journal of Medicinal Chemistry. 37(24). 4073–4075. 6 indexed citations
10.
Lee, Moses, et al.. (1993). In vitro cytotoxicity of GC sequence directed alkylating agents related to distamycin. Journal of Medicinal Chemistry. 36(7). 863–870. 37 indexed citations
11.
Berardini, Mark, et al.. (1993). Two structurally related diaziridinylbenzoquinones preferentially cross-link DNA at different sites upon reduction with DT-diaphorase. Biochemistry. 32(13). 3306–3312. 32 indexed citations
12.
Hartley, J.A., John P. Bingham, & Robert L. Souhami. (1992). DNA sequence selectivity of guanine-N7 alkylation by nitrogen mustards is preserved in intact cells. Nucleic Acids Research. 20(12). 3175–3178. 46 indexed citations
13.
Hartley, J.A., Mark Berardini, John Butler, et al.. (1992). Alteration in DNA cross-linking and sequence selectivity of a series of aziridinylbenzoquinones after enzymic reduction by DT-diaphorase. Biochemistry. 31(11). 3019–3025. 45 indexed citations
14.
Chresta, Christine M., et al.. (1992). Potentiation of etoposide-induced cytotoxicity and DNA damage in CCRF-CEM cells by pretreatment with non-cytotoxic concentrations of arabinosyl cytosine. Cancer Chemotherapy and Pharmacology. 31(2). 139–145. 8 indexed citations
15.
Hartley, J.A., Mark Berardini, Mauro Ponti, et al.. (1991). DNA crosslinking and sequence selectivity of aziridinylbenzoquinones: a unique reaction at 5'-GC-3' sequences with 2,5-diaziridinyl-1,4-benzoquinone upon reduction. Biochemistry. 30(50). 11719–11724. 33 indexed citations
16.
Wassermann, Karsten, J. William Lown, J.A. Hartley, et al.. (1990). Liblomycin-mediated DNA cleavage in human head and neck squamous carcinoma cells and purified DNA.. PubMed. 50(6). 1732–7. 3 indexed citations
17.
Hartley, J.A., Stephen Forrow, & Robert L. Souhami. (1990). Effect of ionic strength and cationic DNA affinity binders on the DNA sequence selective alkylation of guanine N7-positions by nitrogen mustards. Biochemistry. 29(12). 2985–2991. 22 indexed citations
18.
Hartley, J.A., et al.. (1990). Photosensitization of human leukemic cells by anthracenedione antitumor agents.. PubMed. 50(6). 1936–40. 22 indexed citations
19.
Krowicki, Krzysztof, J.A. Hartley, Brian Ward, et al.. (1988). Molecular recognition between oligopeptides and nucleic acids rational design of sequence specific dna binding agents. 251–272. 5 indexed citations
20.
Hartley, J.A., et al.. (1985). Association of DNA strand breaks with accelerated terminal differentiation in mouse epidermal cells exposed to tumor promoters.. PubMed. 45(10). 4864–70. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Caroline O’Hare Breakdown of academic impact, for papers by James D. Liddil Breakdown of academic impact, for papers by C. Yu Breakdown of academic impact, for papers by Mark D. Prairie Breakdown of academic impact, for papers by Judith Markovits Breakdown of academic impact, for papers by Kazuhiro Fukasawa Breakdown of academic impact, for papers by Gregory A. Rener Breakdown of academic impact, for papers by A. S. Prakasha Gowda Breakdown of academic impact, for papers by Rita Fiaschi Breakdown of academic impact, for papers by Eduardo J. Salustiano
Rankless by CCL
2026